Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT06535945

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Led by Rennes University Hospital · Updated on 2025-12-09

400

Participants Needed

8

Research Sites

161 weeks

Total Duration

On this page

Sponsors

R

Rennes University Hospital

Lead Sponsor

M

Ministry of Health, France

Collaborating Sponsor

AI-Summary

What this Trial Is About

To verify whether albumin administration to achieve serum concentration above 30g/L (treated group) and its maintenance within plasmatic physiologic range (above 30 g/L) for five days diminishes rate of AKI at Day 7 after liver transplantation as compared to restrained albumin administration (when serum concentration is at 20 g/L or below (control)).

CONDITIONS

Official Title

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male and female subjects equal or above 18 yrs old.
  • Recipients of primary liver allografts from a deceased donor (including after cardiac death) and as a single organ (liver only).
  • Capability of understanding the purpose and risks of the study.
  • Written informed consent
Not Eligible

You will not qualify if you...

  • Fulminant hepatitis
  • Kidney injury at baseline (Estimated Glomerular Filtration Rate < 50 ml/min in Modification of diet in renal disease-6) including hepatorenal syndrome
  • Use of an induction agent Basiliximab at liver transplantation
  • Protected person (adults legally protected, under judicial protection, guardianship, or supervision), person deprived of their liberty
  • At the time of randomisation, participation to another interventional study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

08_CHRU de Tours Hôpital Trousseau

Chambray-lès-Tours, France, 37170

Actively Recruiting

2

03_APHP Hôpital Beaujon

Clichy, France, 92110

Actively Recruiting

3

04_CHU de Lille Hôpital Huriez

Lille, France, 59000

Not Yet Recruiting

4

05_HCL Hôpital de la Croix Rousse

Lyon, France, 69004

Actively Recruiting

5

06_CHU de Montpellier Hôpital St Eloi

Montpellier, France, 34295

Actively Recruiting

6

02_CHU de Bordeaux - Hôpital Haut Leveque

Pessac, France, 33604

Actively Recruiting

7

01_CHU de Rennes Hôpital Pontchaillou

Rennes, France, 35000

Actively Recruiting

8

09_APHP Hôpital Paul Brousse

Villejuif, France, 94804

Not Yet Recruiting

Loading map...

Research Team

L

Loïc JACOB

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here